美国 · 平台与数据 · Morningstar

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026

来源：Morningstar · 美国 16 小时前

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its…

在 Morningstar 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.morningstar.com)

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026

推荐阅读

Looking Beyond the S&P 500? These 2 International ETFs Offer Very Different Opportunities

XY Planning Network Inc. Sells 5,331 Shares of NVIDIA Corporation $NVDA

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Story3 Capital Partners buys $2.25M in Rent the Runway shares

Global X Equal Weight Can Insurance Idx ETF declares CAD 0.06 dividend

Fastenal (FAST) Stock Looks Rich Even After Stronger Earnings

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026

分享

推荐阅读

Looking Beyond the S&P 500? These 2 International ETFs Offer Very Different Opportunities

XY Planning Network Inc. Sells 5,331 Shares of NVIDIA Corporation $NVDA

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Story3 Capital Partners buys $2.25M in Rent the Runway shares

Global X Equal Weight Can Insurance Idx ETF declares CAD 0.06 dividend

Fastenal (FAST) Stock Looks Rich Even After Stronger Earnings